Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Invested Capital (2022 - 2025)

Historic Invested Capital for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to $411.4 million.

  • Centessa Pharmaceuticals' Invested Capital fell 1757.97% to $411.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $411.4 million, marking a year-over-year decrease of 1757.97%. This contributed to the annual value of $510.5 million for FY2024, which is 11608.38% up from last year.
  • As of Q3 2025, Centessa Pharmaceuticals' Invested Capital stood at $411.4 million, which was down 1757.97% from $454.5 million recorded in Q2 2025.
  • Over the past 5 years, Centessa Pharmaceuticals' Invested Capital peaked at $510.5 million during Q4 2024, and registered a low of $215.2 million during Q1 2024.
  • Moreover, its 4-year median value for Invested Capital was $372.9 million (2022), whereas its average is $369.9 million.
  • As far as peak fluctuations go, Centessa Pharmaceuticals' Invested Capital crashed by 3892.32% in 2023, and later surged by 13029.01% in 2025.
  • Quarter analysis of 4 years shows Centessa Pharmaceuticals' Invested Capital stood at $336.2 million in 2022, then decreased by 29.72% to $236.2 million in 2023, then soared by 116.08% to $510.5 million in 2024, then dropped by 19.41% to $411.4 million in 2025.
  • Its Invested Capital was $411.4 million in Q3 2025, compared to $454.5 million in Q2 2025 and $495.5 million in Q1 2025.